BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 1652590)

  • 21. Plasminogen activation system in oral cancer: Relevance in prognosis and therapy (Review).
    Wyganowska-Świątkowska M; Jankun J
    Int J Oncol; 2015 Jul; 47(1):16-24. PubMed ID: 26004216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
    Bergonzelli GE; Kruithof EK
    J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.
    Seiffert D; Mimuro J; Schleef RR; Loskutoff DJ
    Cell Differ Dev; 1990 Dec; 32(3):287-92. PubMed ID: 1711915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cell fibrinolysis: transcriptional regulation of fibrinolytic protein gene expression (t-PA, u-PA, and PAI-1) by low alcohol.
    Booyse FM; Aikens ML; Grenett HE
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1119-24. PubMed ID: 10397301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.
    Andreasen PA; Sottrup-Jensen L; Kjøller L; Nykjaer A; Moestrup SK; Petersen CM; Gliemann J
    FEBS Lett; 1994 Feb; 338(3):239-45. PubMed ID: 8307187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activators and plasminogen activator inhibitors: biochemical aspects.
    Rijken DC
    Baillieres Clin Haematol; 1995 Jun; 8(2):291-312. PubMed ID: 7549064
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.